Clinical Trial Detail

NCT ID NCT03565991
Title Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer
Indications

Advanced Solid Tumor

Therapies

Avelumab + Talazoparib

Age Groups: senior adult

Additional content available in CKB BOOST